Recruiting
Phase 1

Calaspargase Pegol-Mnkl & Cobimetinib

Sponsor:

OHSU Knight Cancer Institute

Code:

NCT05034627

Conditions

Locally Advanced Pancreatic Adenocarcinoma

Metastatic Pancreatic Adenocarcinoma

Stage II Pancreatic Cancer AJCC v8

Stage IIA Pancreatic Cancer AJCC v8

Stage IIB Pancreatic Cancer AJCC v8

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Biopsy

Calaspargase Pegol-mknl

Cobimetinib

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-05-22. This information was provided to ClinicalTrials.gov by OHSU Knight Cancer Institute on 2024-10-28.